MARKHAM, Ontario, July 14, 2023 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a "Common Share") for the month of July 2023, representing $0.936 per Common Share on an annualized basis.
The dividend will be payable on August 15, 2023 to shareholders of record as at July 31, 2023.
The Company's dividends are designated as eligible dividends for Canadian tax purposes in accordance with subsection 89(14) of the Income Tax Act (Canada), and any applicable corresponding provincial and territorial legislation.
About Sienna Senior Living
Sienna Senior Living Inc. (TSX:SIA) offers a full range of seniors' living options, including independent living and assisted living under its Aspira retirement brand, long-term care, and specialized programs and services. Sienna's approximately 12,000 employees are passionate about cultivating happiness in daily life. For more information, please visit www.siennaliving.ca.
For further information, please contact: David Hung Chief Financial Officer & Executive Vice President (905) 489-0258 [email protected]
The Memorial Health System (MHS) partnered with InVita Healthcare Technologies (InVita), Oracle Health, and Mississippi Organ Recovery Agency (MORA), the federally designated Organ Procurement Organization (OPO) serving most of the state of...
YS Biopharma Co., Ltd. ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and...
As a bill holding oil drillers accountable for health harms awaits a vote on the California Assembly Floor, Chevron reported spending $3 million lobbying in the first three months of the year to defeat that bill, AB 3155, the only bill it claims to...
Great Place to Work Institute and its senior care partner, Activated Insights, have once again honored Clearwater Living with certification as a Great Place to Work. This accolade marks the fifth time the company has participated in the survey and...
Envista Holdings Corporation ("Envista") today announced that the company will participate in the Stifel Jaws & Paws Conference on Wednesday, May 29, 2024 from 4:10 ? 4:40 pm ET in a Fireside Chat. There will be an audio-only recording link that can...
Neurocrine Biosciences, Inc. today announced the publication of data from a post hoc analysis of the Phase 3 KINECT®-4 study of INGREZZA® (valbenazine) capsules in the Journal of Clinical Psychopharmacology. The analysis assessed long-term outcomes...
